Omacor

Omacor

Manufacturer:

BASF AS

Distributor:

Patriot
Concise Prescribing Info
Contents
EPA 460 mg, DHA 380 mg
Indications/Uses
Isolated or predominant endogenous hypertriglyceridemia in patient at risk of ischemic heart disease &/or pancreatitis; supplement to diet when appropriate & assiduous dietary measures alone are insufficient to produce an adequate response.
Dosage/Direction for Use
Hypertriglyceridemia Initially 2 cap daily may be increased to 4 cap daily.
Administration
Should be taken with food: Take w/ food to avoid GI disturbances.
Contraindications
Hypersensitivity to EPA or DHA, soya (soya milk, soya beans). Contains peanut or soya.
Special Precautions
Patients w/ known sensitivity or allergy to fish. Thromboxane A2 production may fall during treatment. Monitor patients receiving anticoagulant or other drugs affecting coagulation (eg, ASA, warfarin & coumarin). Routine monitoring of the entire lipid profile; LDL-C especially in patients w/ type IV & V dyslipidemia. Not recommended as monotherapy in type IIb dyslipidemia. Regular monitoring of hepatic function (especially ALT) in patients w/ hepatic impairment. Pregnancy (category B1) & lactation. Childn & adolescent. Elderly ≥70 yr.
Adverse Reactions
GI disorders (including abdominal distension/pain, constipation, diarrhea, dyspepsia, flatulence, eructation, GERD, nausea or vomiting.
Drug Interactions
Increased bleeding time w/ ASA, warfarin; coumarin.
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AX06 - omega-3-triglycerides incl. other esters and acids ; Belongs to the class of other lipid modifying agents.
Presentation/Packing
Form
Omacor softgel
Packing/Price
28's (P766.55/pack)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in